The mechanism for benzodiazepine withdrawal-induced metamorphosis is unknown. Possibly benzodiazepine withdrawal leads to a reduction in gamma-aminobutyric acid with associated disinhibition phenomenon and thus positive symptoms occur. While metamorphosis has been described with occipital/occipitotemporal lobe lesions (Pryse-Phillips, 2003), no such pathology was noted in this patient. In those who undergo benzodiazepine withdrawal, query as to metamorphosis is warranted. Alternatively, in those presenting with metamorphosis, investigation into benzodiazepine use may be revealing.
Pryse-Phillips, W. (2003). Companion to clinical neurology. New York: Oxford University Press.
Seens, H., & Hirsch A. (2018). T214. Two Sisters Too Many: A Case of Benzodiazepine Withdrawal-Induced Reduplicative Paramnesia. Biological Psychiatry, 83(9), S211.